Approaches for chemically synthesized siRNA and vector-mediated RNAi.
about
Role of human mitochondrial Nfs1 in cytosolic iron-sulfur protein biogenesis and iron regulationAntiviral silencing in animalsMicroRNAs: control and loss of control in human physiology and diseasePseudovirions as vehicles for the delivery of siRNAFighting against kidney diseases with small interfering RNA: opportunities and challengesPoly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesisAerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery SystemsLentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAsComparison of chicken 7SK and U6 RNA polymerase III promoters for short hairpin RNA expressionSequence-non-specific effects of RNA interference triggers and microRNA regulators.Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivoAdvances in Systemic siRNA DeliveryDevelopment of an efficient recombinant mosquito densovirus-mediated RNA interference system and its preliminary application in mosquito control.Emergence of a complex relationship between HIV-1 and the microRNA pathway.Broad-spectrum antiviral activity of RNA interference against four genotypes of Japanese encephalitis virus based on single microRNA polycistrons.Genetically encoded light-activated transcription for spatiotemporal control of gene expression and gene silencing in mammalian cells.A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cellsInhibition of osteoclastogenesis by RNA interference targeting RANK.Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance RegulatorApplication of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancersReduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells.Targeting Human Telomerase Reverse Transcriptase by a Simple siRNA Expression Cassette in HepG2 Cells.Chemistry of nucleic acids: impacts in multiple fields.Harnessing RNAi nanomedicine for precision therapyHydrophobization and bioconjugation for enhanced siRNA delivery and targetingRNA interference targeting virion core protein ORF095 inhibits Goatpox virus replication in Vero cells.Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencingThree new shRNA expression vectors targeting the CYP3A4 coding sequence to inhibit its expressionAerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery SystemsExploring in vitro roles of siRNA in cardiovascular disease.Using RNA-mediated interference feeding strategy to screen for genes involved in body size regulation in the nematode C. elegans.Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism.Modulating the expression of disease genes with RNA-based therapy.Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: novel options by phosphorothioate-stimulated delivery.Guidelines for the optimal design of miRNA-based shRNAs.An Algorithm for Generating Small RNAs Capable of Epigenetically Modulating Transcriptional Gene Silencing and Activation in Human Cells.Expression strategies for short hairpin RNA interference triggers.Target validation to biomarker development: focus on RNA interference.Identification and characterization of buffalo 7SK and U6 pol III promoters and application for expression of short hairpin RNAs.
P2860
Q24297460-4BF26459-A467-485E-9171-446DBF5C46F1Q24539005-F26AA13A-496A-4289-A523-23C5C770443EQ24618771-1E6DD393-E2EC-414A-AD42-24873B6D54D8Q24634231-3BB81A44-1E54-4559-94FD-4943E5F7B193Q27010574-75B2262A-6560-402F-8B42-23BB889E75F0Q28384723-D4D7854A-0A5D-4F6B-AF63-D067651B92FAQ28392004-082F35E2-7070-4359-B119-0FA1B31B2FE6Q33291003-D5BA4D66-BA09-4715-866F-B8E3485627BDQ33304401-E6063C5B-EFA9-409C-868E-4F9D43922D0BQ33306167-AE426024-1B8B-484A-BB3B-20A93C405D55Q33566425-746034B8-3100-4D0B-9B21-9C7EBA8F7076Q33598470-BD6DB9F9-2CFD-4064-8F58-601D1D6E7A38Q33613316-54F07516-7F4E-419E-BAB5-73A1E9136F76Q33940719-DE82DF1D-10DD-425E-9226-AA0C280798FDQ34025960-3B2EC542-F588-4F94-863A-9F0F416D78D5Q34058502-CF5F1905-DCFB-46C5-85A0-FEE529F784ECQ34303305-F4031808-40C9-4EC4-8B2F-0625FFDA53F8Q34329463-8BAAC70C-6B9B-43F6-BC98-973D664187B8Q34389834-A5C1CACE-2E65-4EEE-8747-80F76B165516Q34534598-FBA3D986-1E1A-478C-9640-5F2578005EC2Q34556898-002F627A-8714-44D4-BAE9-AF015725AB49Q35225062-F1E89876-8532-461E-BD76-F0502D48A8D7Q35267153-B2504B57-ED3B-4A82-BF86-F214B610F6C5Q35652657-5ADD5A8E-D475-4556-BD61-25EB89FB6EC0Q35673875-7EA05F2A-6E93-4406-BAD9-47DDA5CDB6EBQ35697443-15FB66E9-E4F5-4024-84A7-011E160B17D4Q35819608-B98F9018-D7EE-40A9-8E8B-0CD989FF32DCQ35946601-ADC93F3F-3BEC-431F-998E-13ED9A79519AQ36237599-C4159227-BD0C-4BBA-8F66-935D81542D02Q36341433-256542E6-6A1C-4257-A4A7-4016FDB2B2ADQ36690431-E1E9AF74-1A06-4BD3-97AD-7DDC43CA9627Q36695016-337948A6-BC0B-43F1-AB5E-E9849AC235FBQ36835045-1AE7D5F7-BE91-4340-ACBA-4655A48DE572Q36866549-C17CA099-0310-478B-93F0-BB57A559649EQ36960492-AA23FA2B-268B-4EBD-8335-2F52048D4955Q37038732-584559D3-9367-4BFF-9131-0DCE7B5CE69AQ37065556-580E8EFB-7092-4FB0-B0C5-96337DFA278AQ37117812-8878AFEF-4F84-45F3-A4B1-A4E638321D90Q37141990-49196586-B85C-4E7B-89C7-FFECD696B57FQ37645255-6C74D70A-487A-43D2-85DC-14FC29442363
P2860
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@ast
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@en
type
label
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@ast
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@en
prefLabel
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@ast
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@en
P2093
P2860
P1433
P1476
Approaches for chemically synthesized siRNA and vector-mediated RNAi.
@en
P2093
Dongho Kim
John J Rossi
Mohammed Amarzguioui
P2860
P304
P356
10.1016/J.FEBSLET.2005.08.070
P407
P577
2005-09-20T00:00:00Z